Quinuclidine-Based Carbamates as Potential CNS Active Compounds

The treatment of central nervous system (CNS) diseases related to the decrease of neurotransmitter acetylcholine in neurons is based on compounds that prevent or disrupt the action of acetylcholinesterase and butyrylcholinesterase. A series of thirteen quinuclidine carbamates were designed using qui...

Descripción completa

Detalles Bibliográficos
Autores principales: Matošević, Ana, Radman Kastelic, Andreja, Mikelić, Ana, Zandona, Antonio, Katalinić, Maja, Primožič, Ines, Bosak, Anita, Hrenar, Tomica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8003920/
https://www.ncbi.nlm.nih.gov/pubmed/33804719
http://dx.doi.org/10.3390/pharmaceutics13030420

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8003920/
https://www.ncbi.nlm.nih.gov/pubmed/33804719
http://dx.doi.org/10.3390/pharmaceutics13030420

Ejemplares similares